ArticleBlood advances2023

Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia.

Anjali S Advani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.